Clinical Trials Directory

Trials / Completed

CompletedNCT06761625

Changes in Hormonal Profile and Body Mass Index in Women With Polycystic Ovary Syndrome After Probiotic Intake

Changes in Hormonal Profile and Body Mass Index in Women With Polycystic Ovary Syndrome After Probiotic Intake: A 12-week Placebo Controlled and Randomized Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Pomeranian Medical University Szczecin · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

Changes in hormonal profile and body mass index in women with polycystic ovary syndrome were analised after probiotic intake.

Detailed description

50 women with PCOS , diagnosed based on Rotterdam ESHRE criteria,were assigned to two groups - the probiotics one and the placebo one. Women from the probiotics group were given SanProbi® Barrier capsules. They were taking probiotics for 12 weeks. The placebo group received identical-looking capsules filled mainly with maize starch and maltodextrins. The study concentrates on analysing specific hormones before and after the intervention (giving the probiotics or a placebo to the patients). The serum samples were obtained on days 3-5 (early follicular phase) of menstrual cycle. In the laboratory studies, the following hormones were measured before and after 12-week intervention: Testosterone, Androstenedione, 17-hydroxyprogesterone (17(OH)P); follicle stimulating hormone (FSH), luteinising hormone (LH); estradiol (E2), prolactin (PRL), thyroid stimulating hormone (TSH), thyroxine (T4) and sex hormone binding globulin (SHBG). The weight and height were measured before and after 12-week intervention. BMI was also calculated.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSanProbi® Barrier capsulesThe probiotic group received SanProbi® Barrier capsules
OTHERPlaceboThe placebo group received capsules filled mainly with maize starch and maltodextrins.

Timeline

Start date
2019-12-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2025-01-07
Last updated
2025-01-07

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06761625. Inclusion in this directory is not an endorsement.